Clinical trial
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy…
NCT00433485 · Yale University, Other · Completed
Key facts
| NCT number | NCT00433485 |
|---|---|
| Title | Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants |
| Official title | In Vivo and In Vitro Pharmacology of Sirolimus in Subjects With Basal Cell Nevus Syndrome |
| Lead sponsor | Yale University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplastic Syndrome, Non-melanomatous Skin Cancer |
| Intervention type | Drug, Genetic, Other, Procedure |
| Interventions | sirolimus, comparative genomic hybridization, gene expression analysis, microarray analysis, protein expression analysis, proteomic profiling, laboratory biomarker analysis, mass spectrometry, biopsy |
| Enrollment | 16 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Feb 12, 2007 |
| Last update posted | Sep 23, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: